Triple-Threat attack on tough liver cancer shows promise
NCT ID NCT07230080
Summary
This study is looking at a three-part treatment for people with intermediate to advanced liver cancer who cannot have surgery. It combines a procedure to cut off the tumor's blood supply and deliver chemo, followed by precise radiation and a drug that helps the immune system fight cancer. The main goal is to see if this combination can shrink tumors effectively and safely.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanfang Hosptial
Guangzhou, China
Conditions
Explore the condition pages connected to this study.